112 related articles for article (PubMed ID: 2783951)
1. Elevated plasma interleukin-1 levels in humans following ultraviolet light therapy for psoriasis.
Konnikov N; Pincus SH; Dinarello CA
J Invest Dermatol; 1989 Feb; 92(2):235-9. PubMed ID: 2783951
[TBL] [Abstract][Full Text] [Related]
2. T cells in psoriatic lesional skin that survive conventional therapy with NB-UVB radiation display reduced IFN-gamma expression.
Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
Arch Dermatol Res; 2004 May; 295(12):509-16. PubMed ID: 15024577
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate, but not narrowband ultraviolet B radiation, suppresses interleukin-33 mRNA levels in psoriatic plaques and protein levels in serum of patients with psoriasis.
Meephansan J; Subpayasarn U; Ponnikorn S; Chakkavittumrong P; Juntongjin P; Komine M; Ohtsuki M; Poovorawan Y
J Dermatol; 2018 Mar; 45(3):322-325. PubMed ID: 28836690
[TBL] [Abstract][Full Text] [Related]
4. [Mechanisms of immune suppression of systemic inflammation by the action of the narrowband ultraviolet B (311 nm) therapy in patients with psoriasis].
Babanin VA
Lik Sprava; 2013; (3):97-102. PubMed ID: 25016757
[TBL] [Abstract][Full Text] [Related]
5. Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy.
Kikuchi K; Wakamatsu K; Tada Y; Komine M; Ito S; Tamaki K
Clin Exp Dermatol; 2008 Nov; 33(6):750-3. PubMed ID: 18954414
[TBL] [Abstract][Full Text] [Related]
6. Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers -- IL-12, IL-18 and IL-23.
Piskin G; Tursen U; Sylva-Steenland RM; Bos JD; Teunissen MB
Exp Dermatol; 2004 Dec; 13(12):764-72. PubMed ID: 15560760
[TBL] [Abstract][Full Text] [Related]
7. Narrowband-UVB irradiation decreases the production of pro-inflammatory cytokines by stimulated T cells.
Sigmundsdottir H; Johnston A; Gudjonsson JE; Valdimarsson H
Arch Dermatol Res; 2005 Jul; 297(1):39-42. PubMed ID: 15889264
[TBL] [Abstract][Full Text] [Related]
8. Whole-body UVB (TL-01) or UVA-1 irradiation does not alter the levels of immunomodulatory cytokines in the serum of human volunteers.
McLoone P; Man I; Yule S; Fluitman A; Van Loveren H; Norval M; Gibbs NK
Photodermatol Photoimmunol Photomed; 2004 Apr; 20(2):76-80. PubMed ID: 15030591
[TBL] [Abstract][Full Text] [Related]
9. Disruption of circulating CD4+ T-lymphocyte subpopulations in psoriasis patients is ameliorated by narrow-band UVB therapy.
Wang X; Wang G; Gong Y; Liu Y; Gu J; Chen W; Shi Y
Cell Biochem Biophys; 2015 Jan; 71(1):499-507. PubMed ID: 25269772
[TBL] [Abstract][Full Text] [Related]
10. Photoadaptation to ultraviolet (UV) radiation in vivo: photoproducts in epidermal cells following UVB therapy for psoriasis.
Bataille V; Bykov VJ; Sasieni P; Harulow S; Cuzick J; Hemminki K
Br J Dermatol; 2000 Sep; 143(3):477-83. PubMed ID: 10971317
[TBL] [Abstract][Full Text] [Related]
11. Systemically elevated Th1-, Th2- and Th17-associated chemokines in psoriasis vulgaris before and after ultraviolet B treatment.
Ekman AK; Sigurdardottir G; Carlström M; Kartul N; Jenmalm MC; Enerbäck C
Acta Derm Venereol; 2013 Sep; 93(5):527-31. PubMed ID: 23571825
[TBL] [Abstract][Full Text] [Related]
12. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
Beani JC; Jeanmougin M
Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064
[TBL] [Abstract][Full Text] [Related]
13. Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Br J Dermatol; 2010 Dec; 163(6):1282-90. PubMed ID: 20716219
[TBL] [Abstract][Full Text] [Related]
14. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the mechanism of ultraviolet (UV) B radiation-induced prostaglandin E2 synthesis by human epidermoid carcinoma cells.
Grewe M; Trefzer U; Ballhorn A; Gyufko K; Henninger H; Krutmann J
J Invest Dermatol; 1993 Oct; 101(4):528-31. PubMed ID: 8409518
[TBL] [Abstract][Full Text] [Related]
16. IL-4 expression by neutrophils in psoriasis lesional skin upon high-dose UVB exposure.
Piskin G; Tursen U; Bos JD; Teunissen MB
Dermatology; 2003; 207(1):51-3. PubMed ID: 12835549
[TBL] [Abstract][Full Text] [Related]
17. Cellular and molecular effects of pulsed dye laser and local narrow-band UVB therapy in psoriasis.
Rácz E; de Leeuw J; Baerveldt EM; Kant M; Neumann HA; van der Fits L; Prens EP
Lasers Surg Med; 2010 Mar; 42(3):201-10. PubMed ID: 20333742
[TBL] [Abstract][Full Text] [Related]
18. Reduced IL-1Ra/IL-1 ratio in ultraviolet B-exposed skin of patients with polymorphic light eruption.
Janssens AS; Pavel S; Tensen CP; Teunissen MB; Out-Luiting JJ; Willemze R; de Gruijl FR
Exp Dermatol; 2009 Mar; 18(3):212-7. PubMed ID: 19046297
[TBL] [Abstract][Full Text] [Related]
19. Association of cyclosporine and 311 nM UVB in the treatment of moderate to severe forms of psoriasis: a new strategic approach.
Franchi C; Cainelli G; Frigerio E; Garutti C; Altomare GF
Int J Immunopathol Pharmacol; 2004; 17(3):401-6. PubMed ID: 15461875
[TBL] [Abstract][Full Text] [Related]
20. Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways.
Rácz E; Prens EP; Kurek D; Kant M; de Ridder D; Mourits S; Baerveldt EM; Ozgur Z; van IJcken WF; Laman JD; Staal FJ; van der Fits L
J Invest Dermatol; 2011 Jul; 131(7):1547-58. PubMed ID: 21412260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
